Speciality Medicines (SPML) Share Price Falls 8.21% on Trading Sector Valuation Check

Speciality Medicines Share Price fell to Rs 156, down 8.21% today, while the company's market capitalisation stood at Rs 149.31 crore. Speciality Medicines Share Price movement is notable because the stock traded at its day's open, high and low of Rs 156, which keeps the intraday picture very tight even as the share price decline is visible from the previous close of Rs 169.95. Univest figures confirm the price action, but they do not point to a specific company trigger. For readers tracking Speciality Medicines Share Price Today, the change is relevant because it combines a sharp percentage fall with a Micro Cap profile, a trading-sector classification and a valuation set that can be compared against the broader same-industry universe. Speciality Medicines Stock News therefore centres on price action, valuation and peer context rather than any verified event trigger. Speciality Medicines Share Price also matters for investors monitoring Speciality Medicines Share Price Live and Speciality Medicines Share Price Update on Univest.

Speciality Medicines (SPML) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 156
Previous Close	Rs 169.95
Today's Move	-Rs 13.95 (-8.21%)
Open	Rs 156
High	Rs 156
Low	Rs 156
Market Capitalisation	Rs 149.31 crore
Market Cap Category	Micro Cap

Speciality Medicines Share Price Today shows a straightforward downward move: the stock last traded at Rs 156 against the previous close of Rs 169.95, a decline of Rs 13.95 or 8.21%. Speciality Medicines Share Price opened at Rs 156, touched a high of Rs 156 and a low of Rs 156, so the entire range matched the trade print seen in the current session. That makes Speciality Medicines Share Price easy to read from a price action point of view: the move was lower, but the intraday range did not extend beyond the opening level. With a market capitalisation of Rs 149.31 crore, the company sits in the Micro Cap category, which is the right size context for Speciality Medicines Share Price Today. Speciality Medicines Stock Falling Today should therefore be understood as a price event first, followed by valuation and sector context. The next layer is Speciality Medicines Fundamental Analysis.

Speciality Medicines (SPML) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 149.31 crore
P/E Ratio	11.46x
P/B Ratio	2.1x
ROE	25.6%
ROCE	25.26%
EPS	Rs 14.83
Book Value Per Share	Rs 81.03
Dividend Yield	0%

Speciality Medicines (SPML) fundamental metrics show P/E 11.46x, P/B 2.1x, ROE 25.6%, ROCE 25.26%. Taken on their own, these numbers offer context rather than a trading signal.

Speciality Medicines has a market capitalisation of Rs 149.31 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 11.46x, P/B at 2.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.6% and ROCE of 25.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 14.83, book value per share of Rs 81.03, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.23x, median ROE of 4.04%, median ROCE of 5.68%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Company P/E Ratio	11.46x
Benchmark Median P/E	22.23x
Benchmark Average P/E	90.22x
Benchmark P/E Range	0.14x to 3,108.78x
Company P/B Ratio	2.1x
Benchmark Median P/B	1.37x
Benchmark Average P/B	4.42x
Company ROE	25.6%
Benchmark Median ROE	4.04%
Benchmark Average ROE	4.2%
Company ROCE	25.26%
Benchmark Median ROCE	5.68%
Benchmark Average ROCE	7.01%
Company Market Capitalisation	Rs 149.31 crore
Benchmark Median Market Cap	Rs 52.98 crore
Benchmark Average Market Cap	Rs 1,506.78 crore

Speciality Medicines (SPML) operates in the Trading sector, within the Trading industry.

Speciality Medicines (SPML) has a P/E ratio of 11.46x, which is below the benchmark median of 22.23x, a difference of -48.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Speciality Medicines (SPML) has a ROE of 25.6%, which is above the benchmark median of 4.04%, a difference of +533.66%. Speciality Medicines (SPML) has a ROCE of 25.26%, which is above the benchmark median of 5.68%, a difference of +344.72%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Adani Enterprises	ADANIENT	3,63,880.63	48.88	3.86	15.07	13.3
ADITYA INFOTECH	CPPLUS	49,843.56	104.43	14.18	25.68	29.48
Aegis Logistics	AEGISLOG	47,955.38	38.33	7.27	20.71	19.76
Premier Energies	PREMIERENE	41,082.61	24.67	8.64	42.6	33.72
Redington	REDINGTON	29,992.78	17.63	2.83	13.6	18.96

Speciality Medicines (SPML) has a P/E ratio of 11.46x compared with the displayed peer median of 38.33x. The comparison is relative and should not be read as a recommendation. Its ROE of 25.6% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 25.26% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Speciality Medicines (SPML) has a market capitalisation of Rs 149.31 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Speciality Medicines

• Speciality Medicines Share Price fell 8.21% today to Rs 156, which makes the price action worth tracking closely.
• Speciality Medicines Share Price Today was uniform across open, high and low, so the move is simple to read from a market data angle.
• Speciality Medicines Fundamental Analysis shows P/E of 11.46, P/B of 2.1, ROE of 25.6% and ROCE of 25.26%.
• Speciality Medicines Market Cap of Rs 149.31 crore places the company in the Micro Cap category.
• Speciality Medicines Stock News gains relevance because the share price fall happened without a verified company-specific catalyst.

About Speciality Medicines

Speciality Medicines operates in the Trading sector and Trading industry. The company is identified in the market as a Micro Cap with a market capitalisation of Rs 149.31 crore. Speciality Medicines Share Price should be viewed in the context of a business that belongs to a broad trading universe rather than a single narrow product segment in the current data. Speciality Medicines Stock News, Speciality Medicines Share News and Speciality Medicines Company News are therefore best tracked through price movement, valuation ratios and sector benchmarks. The company description available here supports only sector and industry positioning, so the main investor takeaway is its place in the trading category and its current ratio profile. Speciality Medicines Share Price remains the core market signal for now.

Track Speciality Medicines Share Price on Univest

Use Speciality Medicines (SPML) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Investors can track Speciality Medicines Share Price on Univest for live price updates, key valuation ratios, 52-week levels, market capitalisation and related market insights. Speciality Medicines Share Price Today can be followed alongside Speciality Medicines Fundamental Analysis and Speciality Medicines Stock News in one place. Univest also helps users compare Speciality Medicines Share Price with sector benchmarks and listed peers in the Trading space.

Frequently Asked Questions

Why is Speciality Medicines Share Price falling today?

Ans. Speciality Medicines Share Price fell 8.21% to Rs 156 today. According to Univest data, no company-specific catalyst is established, so the visible explanation is the price move itself, not a verified event trigger.

What is Speciality Medicines Share Price today?

Ans. Speciality Medicines Share Price today is Rs 156. The stock was down Rs 13.95 from the previous close of Rs 169.95, and the entire session printed at Rs 156 for open, high and low.

How much did Speciality Medicines Share Price decline?

Ans. Speciality Medicines Share Price declined by Rs 13.95 or 8.21% from the previous close. That move also places the current price well below the prior session level, which is the key number in today's trading update.

What is the market capitalisation of Speciality Medicines?

Ans. Speciality Medicines has a market capitalisation of Rs 149.31 crore. That places it in the Micro Cap category, which is useful context when reading Speciality Medicines Share Price and comparing it with the trading sector sample.

What do Speciality Medicines fundamentals show?

Ans. Speciality Medicines Share Price is backed by a P/E of 11.46, P/B of 2.1, ROE of 25.6% and ROCE of 25.26%. EPS is Rs 14.83 and book value is Rs 81.03 per share.

Does Speciality Medicines pay a dividend?

Ans. The dividend yield for Speciality Medicines is 0. That means Speciality Medicines Share Price is not currently supported by a yield-based return measure in the available ratios, so investors may focus on earnings and book value instead.

How does Speciality Medicines compare with sector benchmarks?

Ans. Speciality Medicines Share Price trades on a P/E of 11.46 versus the same-industry median of 22.23. Its ROE of 25.6% and ROCE of 25.26% are also above the benchmark medians of 4.04% and 5.68%.

How does Speciality Medicines compare with peers?

Ans. Speciality Medicines Share Price sits below peers such as Adani Enterprises, Aegis Logistics and CPPLUS on P/E, while its ROE is close to CPPLUS. Relative to Redington, the earnings multiple is lower and the book multiple is also lower.

What should investors monitor next in Speciality Medicines Share Price?

Ans. Investors can monitor whether Speciality Medicines Share Price holds around Rs 156, how valuation compares with the same-industry median, and whether any verified company news appears. Those are the clearest facts available after today's move.